China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Pharmaceutical Group Ltd. has successfully completed the acquisition of Green Cross HK, marking a significant expansion for its subsidiary, CR Boya Bio-pharmaceutical. The acquisition, now finalized, positions Green Cross HK as a wholly-owned subsidiary of CR Boya Bio-pharmaceutical, enhancing the group’s footprint in the biopharmaceutical sector.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.